The Claim
In obese men with hypogonadism receiving GLP-1/GIP therapy, testosterone replacement reduces the proportion of weight loss derived from lean mass from 38% to 26%.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese men with low testosterone who are taking GLP-1/GIP therapy, adding testosterone replacement changes the composition of weight loss so that a smaller percentage comes from muscle tissue and more comes from fat.
See the scientific wording
In obese men with hypogonadism on GLP-1/GIP therapy, testosterone replacement alone reduces the proportion of weight loss derived from lean mass from 38% to 26%, indicating a moderate protective effect on muscle tissue.
Testosterone activates receptors in muscle cells, which turns on pathways that build new muscle proteins and shuts down pathways that break them down. This keeps muscle from being lost when the body is losing weight. Adding protein and exercise makes this effect stronger by providing more building blocks and signaling the muscle to grow.
What the research says
1 studyFor obese men with low testosterone who are losing weight with a special drug, adding testosterone shots cuts the amount of muscle lost in half — from 38% to 26% of total weight loss. The study proves this exactly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.